Study on Red Cell Distribution Width and HbA1C Levels in Adults Over 40 with Type 2 Diabetes After Blood Sugar Control

What this Trial Is About

Type 2 diabetes mellitus T2DM is a widespread chronic condition linked to insulin resistance and reduced insulin secretion, affecting millions worldwide. It can lead to serious complications such as kidney disease, nerve damage, and heart problems. Researchers are investigating the relationship between red cell distribution width RDW, a measure of variation in red blood cell size, and blood sugar control measured by HbA1C in people with T2DM, as RDW may reflect disease activity or complications. This observational study compares people with uncontrolled T2DM and healthy individuals. Blood tests including RDW, HbA1C, and lipid profiles will be taken at the start for both groups. For participants with T2DM, these tests will be repeated after 3 and 6 months to assess changes following glycemic control. The study aims to understand if RDW correlates with blood sugar levels and other health complications related to diabetes. Participants will provide blood samples at recruitment and follow-up visits at 3 and 6 months for the diabetes group. Researchers will measure how RDW and HbA1C levels relate over time and whether RDW changes associate with other illnesses or complications. The study will monitor participants for up to 6 months, tracking these markers to better understand their potential role in diabetes management.

Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control